[HTML][HTML] Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: A systematic review
D Jeremic, L Jiménez-Díaz, JD Navarro-López - Ageing research reviews, 2021 - Elsevier
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in ageing,
affecting around 46 million people worldwide but few treatments are currently available. The …
affecting around 46 million people worldwide but few treatments are currently available. The …
The genetic landscape of basal ganglia and implications for common brain disorders
The basal ganglia are subcortical brain structures involved in motor control, cognition, and
emotion regulation. We conducted univariate and multivariate genome-wide association …
emotion regulation. We conducted univariate and multivariate genome-wide association …
Resilience mechanisms underlying Alzheimer's disease
Alzheimer's disease (AD) consists of two main pathologies, which are the deposition of
amyloid plaque as well as tau protein aggregation. Evidence suggests that not everyone …
amyloid plaque as well as tau protein aggregation. Evidence suggests that not everyone …
Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk
AM Kulminski, I Philipp, L Shu, I Culminskaya - Neurobiology of aging, 2022 - Elsevier
Despite advances, the roles of genetic variants from the APOE-harboring 19q13. 32 region
in Alzheimer's disease (AD) remain controversial. We leverage a comprehensive approach …
in Alzheimer's disease (AD) remain controversial. We leverage a comprehensive approach …
Multi-modal imaging genetics data fusion by deep auto-encoder and self-representation network for Alzheimer's disease diagnosis and biomarkers extraction
Alzheimer's disease (AD) is an incurable neurodegenerative disease, so it is important to
intervene in the early stage of the disease. Brain imaging genetics is an effective technique …
intervene in the early stage of the disease. Brain imaging genetics is an effective technique …
The ApoE locus and COVID-19: are we going where we have been?
CE Finch, AM Kulminski - The Journals of Gerontology: Series A, 2021 - academic.oup.com
Four decades ago in 1985, alleles of apolipoprotein E (ApoE) ε2/ε3/ε4 became famous for
explaining 16% of genetic variance in low-density lipoprotein cholesterol in the benchmark …
explaining 16% of genetic variance in low-density lipoprotein cholesterol in the benchmark …
[PDF][PDF] Network medicine-based epistasis detection in complex diseases: ready for quantum computing
M Hoffmann, JM Poschenrieder, M Incudini… - Nucleic Acids …, 2024 - academic.oup.com
Most heritable diseases are polygenic. To comprehend the underlying genetic architecture,
it is crucial to discover the clinically relevant epistatic interactions (EIs) between genomic …
it is crucial to discover the clinically relevant epistatic interactions (EIs) between genomic …
Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
Background Genetic variants within the APOE locus may modulate Alzheimer's disease (AD)
risk independently or in conjunction with APOE* 2/3/4 genotypes. Identifying such variants …
risk independently or in conjunction with APOE* 2/3/4 genotypes. Identifying such variants …
Haplotype architecture of the Alzheimer's risk in the APOE region via co‐skewness
Introduction As a multifactorial polygenic disorder, Alzheimer's disease (AD) can be
associated with complex haplotypes or compound genotypes. Methods We examined …
associated with complex haplotypes or compound genotypes. Methods We examined …
Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
L Momkute, A Vilkeviciute, G Gedvilaite, G Dubinskaite… - Genes, 2022 - mdpi.com
Optical neuritis (ON), otherwise known as optical nerve damage, is a term used to describe
various environmental and body conditions that lead to optic nerve dysfunction. Neurologists …
various environmental and body conditions that lead to optic nerve dysfunction. Neurologists …